Wenjun Yang

2.1k total citations
64 papers, 1.5k citations indexed

About

Wenjun Yang is a scholar working on Epidemiology, Molecular Biology and Cancer Research. According to data from OpenAlex, Wenjun Yang has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 19 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Wenjun Yang's work include Liver Disease Diagnosis and Treatment (22 papers), Cancer-related molecular mechanisms research (9 papers) and Diet, Metabolism, and Disease (8 papers). Wenjun Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Cancer-related molecular mechanisms research (9 papers) and Diet, Metabolism, and Disease (8 papers). Wenjun Yang collaborates with scholars based in China, United States and Hong Kong. Wenjun Yang's co-authors include Ping Hu, Junping Shi, Longping Wen, Yunfeng Shan, Qiyu Zhang, Yunpeng Sun, Zhenjie Zhuang, Huanhuan Wu, Yan Luo and Qiang Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Wenjun Yang

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjun Yang China 24 696 435 245 161 160 64 1.5k
Aimin Yang China 22 710 1.0× 281 0.6× 188 0.8× 238 1.5× 131 0.8× 93 1.7k
Béatrice Romier France 23 682 1.0× 305 0.7× 267 1.1× 266 1.7× 168 1.1× 41 2.0k
Wei‐Shiung Lian Taiwan 26 951 1.4× 216 0.5× 291 1.2× 206 1.3× 187 1.2× 94 2.0k
Jung‐Hyun Kim South Korea 29 1.4k 2.0× 246 0.6× 254 1.0× 215 1.3× 234 1.5× 94 2.5k
Bin Liang China 28 1.2k 1.7× 298 0.7× 315 1.3× 188 1.2× 262 1.6× 70 2.4k
Jeong Han Kang South Korea 26 781 1.1× 383 0.9× 227 0.9× 150 0.9× 204 1.3× 65 1.8k
Huabing Zhang China 20 962 1.4× 374 0.9× 291 1.2× 414 2.6× 142 0.9× 58 1.9k

Countries citing papers authored by Wenjun Yang

Since Specialization
Citations

This map shows the geographic impact of Wenjun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Yang more than expected).

Fields of papers citing papers by Wenjun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Yang. The network helps show where Wenjun Yang may publish in the future.

Co-authorship network of co-authors of Wenjun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Yang. A scholar is included among the top collaborators of Wenjun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Yang. Wenjun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Wenjun, et al.. (2024). Identifying a survival-associated cell type based on multi-level transcriptome analysis in idiopathic pulmonary fibrosis. Respiratory Research. 25(1). 126–126. 1 indexed citations
3.
Xu, Wei, Shengwen Liu, & Wenjun Yang. (2024). ULBP2 promotes progression of head and neck squamous cell carcinoma by modulating MAPK signaling pathway. Journal of Stomatology Oral and Maxillofacial Surgery. 126(3). 102204–102204.
4.
Song, Yufeng, Chaohua Deng, Zhihui Li, et al.. (2023). Stimulation of Liver Fibrosis by N2 Neutrophils in Wilson’s Disease. Cellular and Molecular Gastroenterology and Hepatology. 16(5). 657–684. 8 indexed citations
5.
Deng, Qian, Shu‐Yuan Xiao, Wenjun Yang, et al.. (2023). Object detection: A novel AI technology for the diagnosis of hepatocyte ballooning. Liver International. 44(2). 330–343. 3 indexed citations
6.
Li, Shao, Jing Liu, Yu Song, et al.. (2022). Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD). Clinica Chimica Acta. 538. 203–210. 5 indexed citations
7.
Wang, Liyan, Lili Zhuo, Jingxin Zhou, et al.. (2021). Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver Disease. Obesity. 29(2). 350–358. 29 indexed citations
8.
Liu, Ying, et al.. (2021). Exogenous H 2 S Protects Colon Cells in Ulcerative Colitis by Inhibiting NLRP3 and Activating Autophagy. DNA and Cell Biology. 40(6). 748–756. 10 indexed citations
9.
Li, Zhihui, Jun Zheng, Zhenjie Zhuang, et al.. (2020). Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(10). 165842–165842. 20 indexed citations
10.
Wang, Fang, et al.. (2019). Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology. 2019. 1–10. 20 indexed citations
11.
Feng, Xue, Zuoyun Wang, Fei Wang, et al.. (2019). Dual function of VGLL 4 in muscle regeneration. The EMBO Journal. 38(17). e101051–e101051. 31 indexed citations
12.
Qian, Weibin, Xinrui Cai, Qiuhai Qian, et al.. (2019). <p>Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway</p>. Drug Design Development and Therapy. Volume 13. 2579–2589. 37 indexed citations
13.
Zheng, Ming‐Hua, Jun Liu, Yan Luo, et al.. (2019). Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis. Obesity. 27(12). 2055–2066. 37 indexed citations
14.
Zhang, Rui & Wenjun Yang. (2017). Circulating Tumor DNA as a Liquid Biopsy in Cancer. 2(1). 2 indexed citations
15.
Chen, Yunzhi, Fang Guo, Hongru Kong, et al.. (2017). Nuclear factor-κB signaling negatively regulates high glucose-induced vascular endothelial cell damage downstream of the extracellular signal-regulated kinase/c-Jun N-terminal kinase pathway. Experimental and Therapeutic Medicine. 14(4). 3851–3855. 3 indexed citations
16.
Yang, Wenjun, et al.. (2017). Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies. World Journal of Surgical Oncology. 15(1). 144–144. 14 indexed citations
17.
Zhuang, Zhenjie, et al.. (2016). Lung Cancer with Diffuse Ground-glass Shadow in Two Lungs and Respiratory Failure. Chinese Medical Journal. 129(15). 1873–1876. 1 indexed citations
18.
Sun, Hongwei, Xiaoli Wu, Fang Wu, et al.. (2015). Associations of Genetic Variants in the PSCA, MUC1 and PLCE1 Genes with Stomach Cancer Susceptibility in a Chinese Population. PLoS ONE. 10(2). e0117576–e0117576. 26 indexed citations
19.
Shi, Zhe, Wenjun Yang, Joyce A. Goldstein, & Shuyun Zhang. (2014). Med25 is required for estrogen receptor alpha (ERα)-mediated regulation of human CYP2C9 expression. Biochemical Pharmacology. 90(4). 425–431. 7 indexed citations
20.
Yang, Wenjun, Yihu Zheng, Han He, et al.. (2011). Inhibition of Trauma-Associated Inflammatory Liver Damage by Blocking NF-κB Activity. Hepatogastroenterology. 59(116). 1174–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026